EDP Sciences logo
Open Access
Ann Toxicol Anal
Volume 24, Numéro 2, 2012
Page(s) 67 - 72
DOI https://doi.org/10.1051/ata/2012011
Publié en ligne 22 juin 2012
  1. Pozo OJ, Van Eenoo P,Deventer K, Delbeke FT. Detection and characterization of anabolic steroids in doping analysis by LC-MS. Tren Anal Chem. 2008; 27(8) : 657–671. [CrossRef] [Google Scholar]
  2. Basaria SJ. Androgen abuse in athletes : detection and consequences. Clin Endocrinol Metab. 2010; 95(4) : 1533–1543. [CrossRef] [Google Scholar]
  3. Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS. Anabolic androgenic steroid use in the United States. J Am Med Ass. 1993; 270(10) : 1217–1221. [CrossRef] [Google Scholar]
  4. Tricker R, O’Neill MR, Cook D. The incidence of anabolic steroid use among competitive bodybuilders. J Drug Ed. 1989; 19(4) : 313–325. [CrossRef] [Google Scholar]
  5. http://www.wada-ama.org/en/World-Anti-Doping-Program/Governments/Investigation–Trafficking/Trafficking/Donati-Report-on-Trafficking/ [Google Scholar]
  6. World Health Organization Geneva, “General Information on counterfeit medicines”, 2006. Available from : http://www.who.int/medicines/services/counterfeit/overview [Google Scholar]
  7. Directive 2011/62/Eu of the European Parliament and of the Council of 8 June 2011. [Google Scholar]
  8. Shackleton CH, Chuang H, Kim J, de la Torre X, Segura J. Electrospray mass spectrometry of testosterone esters : potential for use in doping control. Steroids. 1997; 62(7) : 523–529. [CrossRef] [PubMed] [Google Scholar]
  9. de la Torre X, González JC, Pichini S, Pascual JA, Segura J. 13C/12C isotope ratio MS analysis of testosterone, in chemicals and pharmaceutical preparations. J Pharm Biomed Anal. 2001; 24(4) : 645–650. [CrossRef] [PubMed] [Google Scholar]
  10. Maurer HH. Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control. Clin Chem Lab Med. 2004; 42(11) : 1310–1324. [CrossRef] [PubMed] [Google Scholar]
  11. Segura J, Ventura R, Jurado C. Derivatization procedures for gas chromatographic-mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents. J Chrom B Biomedi Sci Appl. 1998; 713(1) : 61–90. [Google Scholar]
  12. Musshoff F, Daldrup T, Ritsch M. Black market in anabolic steroids-analysis of illegally distributed products. J Forensic Sci. 1997; 42(6) : 1119–1125. [Google Scholar]
  13. Geyer H, Marek-Engelke U, Reinhart U, Thevis M, Schanzer W. The analysis of nutritional supplements for anabolic androgenic steroids. In : Recent advances in doping analysis. Proceedings of the 18th Cologne Workshop on Dope Analysis, Sport und Buch Strauss. 2000; 8 : 23–32. [Google Scholar]
  14. Thevis M, Schrader Y, Thomas A, Sigmund G, Geyer H, Schänzer W. Analysis of Confiscated black market drugs using chromatographic and mass spectrometric approaches. J Anal Toxicol. 2008; 32(3) : 232–240. [PubMed] [Google Scholar]
  15. Geyer H, Parr MK, Koehler K, Mareck U, Schänzer W, Thevis M. Nutritional supplements cross-contaminated and faked with doping substances. J Mass Spectrom. 2008; 43(7) : 892–902. [CrossRef] [PubMed] [Google Scholar]
  16. Pellegrini M, Marchei E, Pacifici R, Rotolo MC, Pichini S. Advances in the analysis of non-allowed pharmacologically active substances in cosmetic products. J Pharm Biomed Anal. 2011; 55(4) : 842–847. [CrossRef] [PubMed] [Google Scholar]
  17. Rotolo MC, Pellegrini M, Bose D, Marchei E, Durgbanshi A, Pichini S. Systematic toxicological analysis of Indian herbal ready-to-chew pouches by gas chromatography mass spectrometry. Ann Toxicol Anal. 2011; 23(4) : 205–210. [CrossRef] [EDP Sciences] [Google Scholar]
  18. Guidance for Industry Bioanalytical Method validation US Department of Health and Human Services. Food and Drug Administration. May 2001. Available at : http://www.fda.gov/cder/guidance/4252fnl.htm [Google Scholar]